All Xconomy Insight

• 

  From Our Editors · Special Report

  Containing Coronavirus Through Innovation and Investment

  Based on the latest news and analysis, as well as conversations from industry experts during the Combatting Coronavirus live panel at BIO-Europe Spring®, our free special report brings you the latest... Read more »

• 

  Sponsored · Special Report

  As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

  The story of the “canary in the coal mine” is an advanced warning of danger. The metaphor originates from when miners used to carry caged canaries while at work; if the... Read more »

  Hughes Marino

• 

  Sponsored · Video

  WellMarker Bio Accelerates the Development of Predictive Biomarker-based Anticancer Drugs

  Dong-Hoon Jin, Founder and CEO of WellMarker Bio Co., Ltd (WMBIO), speaks at BIO-Europe 2019 in Hamburg about their programs focused on predictive biomarker-based anticancer drugs to identity novel targets. WMBIO... Read more »

  WellMarker Bio

• 

  Sponsored · Whitepaper

  How Big Is the US Market for Medical Devices & Technologies?

  This white paper is designed to demonstrate the utility of using the MarketScan® Inpatient View and Outpatient View (now known as IBM® MarketScan® Inpatient View and Outpatient View) online tools to... Read more »

  IBM Watson

• 

  Sponsored · Whitepaper

  IBM Watson Health Data in Action – Epidemiology Studies

  For several decades, IBM® Watson Health™ researchers have been conducting epidemiology and outcomes research, consultation, and collaboration on the execution of pre- and post-launch research agendas. Our researchers and our databases... Read more »

  IBM Watson

• 

  Sponsored · Whitepaper

  The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace

  Over the past several years, the pharmaceutical industry has witnessed significant growth in the biologics sector, with biologics representing more than $150 billion in global sales in 2013. By 2020 they... Read more »

  IBM Watson

• 

  Sponsored · Video

  TILT Bio’s Oncolytic Virus-Enabled T-Cell Therapy Is Ready for Clinical Trials

  Akseli Hemminki, Founder, CEO, and Chairman of the Board of TILT Biotherapeutics, discusses how TILT is different from other immune-therapy companies. Their approach is based on human observations during trials, for... Read more »

  TILT Biotherapeutics

• 

  Sponsored · Video

  Incysus Enters Clinical Trial for Genetically-Modified T Cells for Treating Glioblastoma

  Lawrence Lamb, Executive VP and Chief Scientific Officer at Incysus Therapeutics, tells an inspirational story about the impetus behind the immuno-oncology company’s formation to advance a unique and innovative approach to... Read more »

  Incysus Therapeutics

• 

  Sponsored · Whitepaper

  How to Approach Life Sciences Fundraising

  One of the biggest challenges for life sciences companies is finding sources of funding to keep research and development moving forward. In this guide, we’ll explore the different sources of funding... Read more »

  Brex

• 

  Sponsored · Video

  PRA Health Sciences Leverages Technology & Data to Reinvent Clinical Trial Practices

  PRA Health Sciences executives Sol Babani, Senior VP for Drug Development and Scott Schliebner, Senior VP for the Center for Rare Diseases and Digital Therapeutics, spoke at Biotech Showcase 2020 about... Read more »

  PRA Health Sciences

• 

  Sponsored · Whitepaper

  What’s Next in Neuroscience Therapies

  Brain and neurological disorders are among the toughest conditions to diagnose and treat, but new approaches and technologies are on the horizon that could change how researchers and clinicians approach them.... Read more »

• 

  Sponsored · Video

  Fidelta Focuses on Drug Discovery in Infection & Inflammation

  Fidelta’s Managing Director, Adrijana Vinter, speaks at BIO-Europe® 2019 in Hamburg about her company’s excellence in integrated drug discovery services, from target validation to early preclinical development. The CRO is able... Read more »

  Fidelta

• 

  Sponsored · Whitepaper

  Potency Assay Development for Cell and Gene Therapy Products

  The Issue: Approved biological products are required to be accompanied by analytical tests to demonstrate safety, purity, and potency that are validated and performed under current Good Manufacturing Processes (cGMP)... Read more »

  Absorption Systems

• 

  Sponsored · Video

  BWB TV: Synthego aligns with “Young Innovator” award at the 2019 Xconomy Awards Boston

  Synthego’s Brian Schneider, Territory Account Manager, chats with Xconomy Publisher Brian Caine just before the company presented the “Young Innovator” award at the 2019 Xconomy Awards Boston. He explains the company’s aim... Read more »

  Synthego

• 

  Sponsored · Video

  Bioceros develops monoclonal antibodies as a division of Poland’s Polpharma Biologics Group

  Dr. Louis Boon is Chief Scientific Officer of Bioceros, based in the Netherlands, a division of Poland’s Polpharma Biologics Group, a one-stop-shop CDMO offering novel technologies on their own platform generating... Read more »

  Bioceros

• 

  Sponsored · Video

  Mundipharma’s success rests on valuable like-minded partnerships

  Marco Cerato, Senior VP of Business Development and Strategic Partnerships at Mundipharma, speaks at BIO-Europe® 2019 in Hamburg about how his company’s successes in the market are resulting from a shift... Read more »

  Mundipharma

• 

  Sponsored · Video

  Rousselot Biomedical’s X Pure® is changing the game in purified gelatins

  Jeff Daelman, Business Development Manager at Rousselot Biomedical, speaks at BIO-Europe® 2019 in Hamburg about X-Pure®, an innovative range of purified gelatins and collagens designed explicitly for (bio)medical applications and backed... Read more »

  Rousselot Biomedical

• 

  Sponsored · Video

  PharmAbcine Makes Great Strides in Immune-Oncology Cancer Treatments with Successful Trials

  PharmAbcine’s CEO, Dr. Jin-San Yoo, speaks at BIO-Europe 2019 in Hamburg about the South Korean clinical stage immune-oncology company’s several successful and upcoming clinical trials in Melbourne, Australia, and elsewhere. PharmAbcine... Read more »

  PharmAbcine

• 

  Sponsored · Video

  Rgenix Cancer Therapeutics Company Focuses on RNA to Identify Novel Targets

  Co-founders of Rgenix, CEO Masoud Tavazoie and COO David Darst, speak at BIO-Europe® 2019 in Hamburg about their clinical-stage cancer therapeutics company that focuses on the RNA space to identify novel... Read more »

  Rgenix

• 

  Sponsored · Video

  Nimble Therapeutics Greatly Accelerates Development of Peptide-Based Therapeutics

  Jigar Patel, CEO of Nimble Therapeutics, speaks at BIO-Europe® 2019 in Hamburg about the spin-out last April of Nimble from Roche to accelerate the development and discovery of peptide-based therapeutics, and... Read more »

  Nimble Therapeutics

• 

  Sponsored · Whitepaper

  What to Include in Your Life Sciences Company Fundraising Pitch Deck

  The actual pitch deck you use when pitching biotech investors probably won’t matter quite as much as the delivery of your fundraising pitch. Still, creating that deck is a critical part... Read more »

  Brex

• 

  Sponsored · Video

  Polaryx Therapeutics Boosts Lysosome Biogenesis to Treat Neurodegenerative Disorders

  Hahn-Jun Lee, President and CEO of Polaryx Therapeutics Inc., speaks at BIO-Europe® 2019 in Hamburg about how the company accelerates the availability of treatment options for underserved patients, and what the... Read more »

  Polaryx Therapeutics

• 

  Xconomy Insight · Webinar

  Digital Healthcare Revolution Webinar Series

  While you missed the live webinar, you can still watch a recording by following the link below.

  Register Now for Free

  Wednesday, Nov.... Read more »

• 

  Sponsored · Video

  BWB TV: BREX aligns with “Secret Weapon” award at Xconomy Awards Boston

  Hours before presenting the “Secret Weapon” award at the 2019 Xconomy Awards Boston, BREX’s Matt Henkel, Manager of Business Development and GTM Lead, chatted with Brian Caine, Xconomy’s Publisher. They... Read more »

  BREX

• 

  Xconomy Insight · Webinar

  The New Era of Emerging Therapies Webinar Series

  While you missed the live webinar, you can still watch a recording by following the link below.

  Register Now for Free

  Potential cures... Read more »

• 

  From Our Partners · Webinar

  The Digital Health Revolution

  While you missed the live webinar, you can still watch a recording by following the link below.

  Register Now for Free

  Prepare for... Read more »

• 

  Xconomy Insight · Special Report

  How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook

  This guide goes deeper than the last and gathers advice to help entrepreneurs solve some of the toughest—and often unexpected—challenges of creating a life sciences startup. Where possible, we also provide... Read more »

• 

  Sponsored · Video

  Mass General has success with strategic alliances initiative for research

  Gabriela Apiou, Director of Strategic Alliances at Mass General Research Institute in Boston, explains that the mission of strategic alliances for biomedical research and patient care is the essential retraining of... Read more »

  Massachusetts General Hospital Research Institute

• 

  Sponsored · Video

  Staatz Business Development & Strategy offers high-level consulting

  Dr. Irina Staatz-Granzer, Founder and President of Staatz Business Development & Strategy, describes her biotech and pharma consulting company as having two main areas of expertise, business development and market access.... Read more »

  Staatz Business Development & Strategy

• 

  Sponsored · Video

  Exicure’s CEO describes unique SNA™ technology now in clinical trials

  Dr. David Giljohann, CEO of Exicure, outlines the company’s unique spherical nucleic acid (SNA™) technology and how this three-dimensional arrangement of nucleic acid will solve the delivery challenge to get into... Read more »

  Exicure

• 

  From Our Editors · Special Report

  2019 Biopharma Outlook – Facing an Uncertain Future

  Download this Special Report to learn what 2019 and beyond hold for biopharmaceutical companies, including key indicators that suggest a possible downturn is on the way. You will also read about... Read more »

  Xconomy

• 

  Sponsored · Video

  Biotech Showcase™ 2019: Barc Lab expanding globally to bring personalized approach to more clients

  Sofie Vandevyver, Head of Business Operations and Marketing at Barc Lab, highlights the lab’s goal to help every unique client find the right therapy for the right patient within the... Read more »

  Barc Lab

• 

  Sponsored · Video

  Biotech Showcase™ 2019: Tools4Patient aims to reduce effect of placebo response in clinical trials

  Tools4Patient was founded by a group of industry veterans of clinical trials to accelerate the launch of drugs to patients by developing predictive algorithms to focus on the detrimental placebo response... Read more »

  Tools4Patient

• 

  Sponsored · Video

  Biotech Showcase™ 2019: Barc Lab expanding globally to bring personalized approach to more clients

  Sofie Vandevyver, Head of Business Operations and Marketing at Barc Lab, highlights the lab’s goal to help every unique client find the right therapy for the right patient within the... Read more »

  Barc Lab

• 

  Sponsored · Video

  BIO-Europe® 2018: Life Biosciences aims to solve for aging

  Life Biosciences is the world’s leader in longevity research addressing age-related decline. During BIO-Europe, Sree Kant, Head of Business Development at Life Biosciences, talked with Dr. Cora Kaiser about the company’s... Read more »

  Life Biosciences

• 

  Sponsored · Whitepaper

  Doing Business in a World of Uncertainty

  Just as nature abhors a vacuum, uncertainty provokes similar feelings for business. As this whitepaper makes clear, a growing nationalist and protectionist mindset around the world is creating a fresh set... Read more »

  IDA Ireland

• 

  From Our Partners · Special Report

  Robert Langer reveals secrets to early-stage biotech success

  Download this exclusive profile of Bob Langer—one of 13 Institute Professors at MIT—which features his advice for obtaining funds to get promising technologies from lab to clinic, and where he sees... Read more »

• 

  From Our Partners · Whitepaper

  Cell and Gene Therapies – State Of The Industry Report

  Download from our partner, KNect365 Life Sciences

  It is an exciting time to be involved in the cell and gene therapy industries. There are both opportunities and challenges around analytical testing,... Read more »

• 

  Sponsored · Video

  Big Data in Clinical Trials with Oracle’s MaryAnne Rizk

  PCT TV recently sat down with Dr. MaryAnne Rizk, Global Vice President of Biopharma Partnerships at Oracle, to discuss the biggest challenges facing clinical trials today and how technology can combat... Read more »

• 

  Sponsored · Video

  Interview with Willie Muehlhausen, Head of Innovation, ICON

  PCT TV recently sat down with Willie Muehlhausen, Head of Innovation, ICON to discuss transforming patient trials and patient recruitment. Muehlhausen explored the challenges to patient recruitment in clinical trials and... Read more »

• 

  From Our Partners · Video

  Interview with Nadine Ritter from Global Biotech Experts

  Cheryl Scott, Senior Scientific Editor, BioProcess International Magazine, recently sat down with Nadine M. Ritter, Ph.D., Global BioTech Experts for an interview on the increasing importance of sound product characterization and... Read more »

• 

  From Our Partners · Video

  Interview with Kavita Ramalingam Iyer from Merck Sharp & Dohme

  Anne Montgomery, Editor In Chief, BioProcess International Magazine, recently sat down with Kavita Ramalingam Iyer, PH.D., Associate Director, Global Regulatory Affairs and Clinical Safety – CMC Vaccines at Merck Sharp &... Read more »

  Merck Sharp & Dohme

• 

  Sponsored · Video

  Interview with Jarrod Medeiros from IDBS

  Brian Caine, Publisher, BioProcess International Magazine, recently sat down with Jarrod Medeiros, Product Manager, IDBS at BioTech Week Boston in September to discuss data management and challenges in the pharmaceutical and... Read more »

  IDBS

• 

  Sponsored · Video

  Interview with Jonathan Royce from GE Healthcare

  Brian Caine, Publisher, BioProcess international Magazine, recently sat down with Jonathan Royce, Business Leader Chromatography Resins, GE Healthcare at BioTech Week Boston in September to discuss market trends impacting Monoclonal antibodies.... Read more »

  GE Healthcare

• 

  From Our Editors · Video

  Interview with Lita Nelsen on the Future of Technology Transfer

  Lita Nelsen recently retired as the long-time director of MIT’s Technology Licensing Office. She and Xconomy’s Corie Lok recently sat down for an interview during Biotech Week Boston in September. Nelsen,... Read more »

• 

  From Our Editors · Video

  Interview with David Edwards on the Future of Food

  David Edwards is a professor at Harvard University. He sat down with Xconomy’s Corie Lok during Biotech Week Boston in September to share his vision for the future of food and... Read more »

• 

  From Our Editors · Video

  Interview with David Berry on Microbiome Therapeutics

  David Berry is a general partner with venture capital firm Flagship Pioneering. In recent years, he has co-founded companies that are developing microbiome products for both human therapeutics and agricultural applications.... Read more »

• 

  From Our Editors · Podcast

  Xconomy Voices 02: Christopher Ahlberg of Recorded Future

  Christopher Ahlberg, the CEO of Recorded Future, a cybersecurity startup based in Somerville, MA. Recorded Future has an intriguing approach to solving some of the biggest problems in data and network... Read more »

• 

  From Our Editors · Podcast

  Xconomy Voices 01: Mary Lou Jepsen

  Mary Lou Jepsen is a fearsome samurai when it comes to the design and manufacturing of electronics, especially displays. Her latest venture is Openwater, a San Francisco-based startup that’s using LCDs—the... Read more »

• 

  Xconomy Insight · Special Report

  Trending in Healthcare

  An exploration of the science, technologies and trends with potential to radically change how, when and where people receive healthcare

  Johnson & Johnson Innovation

• 

  From Our Editors · Special Report

  The Sacramento-Davis Corridor: Seeding an Innovation Cluster

  Xconomy presents a two-part series on efforts to transform the Sacramento region into a major new innovation cluster. Part 1 looks at changes in Sacramento that could make the city more... Read more »

• 

  From Our Editors · Special Report

  Madison’s Healthtech Cluster

  Healthcare, agriculture, and manufacturing remain the bread and butter of the private sector in Madison, WI, and the surrounding region, but healthcare IT has arguably become the area’s most buzz-worthy industry.... Read more »

• 

  From Our Editors · Special Report

  Boston Cybersecurity Map

  It’s no secret that the Boston area is home to a formidable group of companies related to cybersecurity. Just how big is the local cluster? Xconomy surveyed the landscape and found... Read more »

• 

  From Our Editors · Slideshow

  12 San Diego Tech Startups to Watch in 2017

  A little more than a year ago, amid a resurgence in San Diego’s software sector, Xconomy identified a baker’s dozen of local tech companies to watch in 2016. The results were... Read more »

• 

  From Our Editors · Special Report

  Xconomist Report: The Future of Education

  For young people today, the view to the future is arguably cloudier than it has been in several generations, thanks to breakneck technological change and increasing economic uncertainty. What kinds of... Read more »

• 

  From Our Editors · Special Report

  Innovation in Santa Cruz

  Wade Roush’s three-part exploration of Santa Cruz’s innovation ecosystem, its history of launching successful companies and entrepreneurs, and its efforts to reverse perceptions that it is anti-business.

  Santa Cruz, the... Read more »